Testicular cancer under control in UK and US

According to figures released by charity Cancer Research UK, survival rates of men having testicular cancer was at 96% a 28% increase from the 70s to 2009.  

The organization is now directing attention to the remaining 4% according to sources. The significant reduction in the mortality rates could be explained by changes in treatment and awareness of testicular cancer according to experts. The 4% either report the disease late or present vary malignant cancer type.

The chief executive of Cancer Research UK, Dr Harpal Kumar believes that this is a clear success story in cancer research which she attributes to the drug cisplatin.  Dr Harpal says "This is helping almost all men with testicular cancer to beat the disease and is a shining example of what we can achieve through dedicated research. The treatment for testicular cancer is so effective that only 1 in 5000 cases fail.

"For some types of cancer, the word 'cure' is almost a reality - 96% of men with testicular cancer are now cured. But it's important we recognize the four per cent who aren't surviving the disease, as well as the fact that we still need treatments to be kinder to patients in the future."

In the UK each year around 2,300 people are diagnosed with the cancer while in the US 7,920 new cases are diagnosed. Testicular cancer is however, uncommon with only 1 in 270 chances of a man developing the disease. The disease mainly presents with a swelling on the testicle.